Market Snapshot
| Study Period: | 2019-2027 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 7.5 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The mechanical ventilators market is expected to register a CAGR of 7.5% during the forecast period (2022 - 2027).
The COVID-19 outbreak has had a positive impact on the mechanical ventilators market due to the increased use of mechanical ventilators in the management of the disease. For instance, according to a research study by Yang Wang et al., published in the American Journal of Respiratory and Critical Care Medicine, in February 2020, 23 (65.7%) patients received invasive ventilation in China. In addition, as per the same source, a total of 134 (40.6%) patients were treated with mechanical ventilation (either non-invasive or invasive), of which 34 received treatment with non-invasive ventilation, whereas 100 patients were given invasive ventilation. Also, the COVID-19 outbreak has increased the demand for respiratory devices like ventilators. For instance, in March 2020, Zoll Medical Corporation planned to increase manufacturing capacity to 10,000 ventilators per month. This production volume expansion helped treat patients suffering from COVID-19, and it may ultimately lead to market expansion. However, this sudden increase in demand for mechanical ventilators is expected to decline with the decline in COVID-19 cases and severely and further, with the ongoing large-scale vaccination program, the demand for mechanical ventilators is expected to reach back to the pre-COVID-19 times and witness a normal growth over the forecast period.
Furthermore, the increasing geriatric population who are more prone to develop chronic diseases as well as the increasing incidences of chronic conditions, such as chronic obstructive pulmonary disease (COPD), are driving the market’s growth. For instance, according to the statistics published by the Australia Bureau of Statistics, in March 2022, 17.6% of females and 10.7% of males aged 75 years or above were having asthma in 2020-2021, in Australia. Also, as per the research study published by the European Respiratory Society (ERS), in September 2021, titled "An estimate of the European prevalence of COPD in 2050", an estimated 36,580,965 Europeans were living with chronic obstructive pulmonary disease in 2020, and this number is projected to reach 49,453,852 people by 2050. Thus, the increasing burden of respiratory diseases among the population is expected to increase the demand for ventilators, thereby propelling the market growth.
However, the highly expensive materials and processes involved in the manufacture of ventilators and higher cost of healthcare systems as well as increasing incidences of ventilator-associated pneumonia are likely to restrain the market growth.
Scope of the Report
As per the scope of the report, mechanical ventilation is an artificial breathing device used for patients who are unable to breathe naturally due to acute medical conditions. These devices are majorly used for patients with spinal cord injury, stroke, respiratory disorders, or other disorders. The Mechanical Ventilators Market is Segmented by Mobility (Intensive Care Ventilators and Portable Ventilators), Interface (Invasive Ventilation and Non-invasive Ventilation), End User (Hospitals, Home Healthcare, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Mobility | |
| Intensive Care Ventilators | |
| Portable Ventilators |
| By Interface | |
| Invasive Ventilation | |
| Non-Invasive Ventilation |
| By End User | |
| Hospitals | |
| Home Healthcare | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Key Market Trends
Intensive Care Ventilators Segment is Expected to Hold Significant Market Share Over the Forecast Period
Intensive care ventilators deliver ventilatory support to patients who cannot breathe on their own or require assistance to maintain adequate ventilation. Neonates and adults can be ventilated using intensive care ventilators, and they can vary in condition, from very critical, unstable patients to relatively stable postoperative patients.
The intensive care ventilators segment is expected to witness significant growth over the forecast period owing to the factors such as rising technological advancements and the increasing focus of manufacturers on developing them.
The demand for mechanical ventilators increased over the past few months due to the COVID-19 outbreak, increasing the number of ICU admissions worldwide. For instance, according to the World Health Organization (WHO), as of May 2021, there were approximately 154,815,600 confirmed cases of COVID-19, including 3,236,104 fatalities. Globally, the rise in COVID-19 patients necessitating both long- and short-term respiratory support may help to fuel the market's expansion.
In January 2021, Inovytec engaged in a deal to supply 1,500 progressive portable ventilators to Italy, Brazil, and Israel. It entered an agreement with a California-based distributor to supply portable ventilators. The portable ventilators may treat individuals with respiratory conditions both during and after the COVID-19 pandemic.
Additionally, notable developments in the intensive care segment contribute to its prominent share in the market. Products such as Spontaneous Breathing Trial (SBT) are used to assess the patient's ability to breathe while receiving minimal or no ventilator support. Also, Auto TRAK improves the patient experience. Thus, the rising advancement in the products is expected to fuel the market growth over the forecast period.
The market players adopt various strategies, such as product launches, collaborations, and acquisitions, to increase their market share. For instance, in December 2020, CorVent Medical entered an arrangement with Siemens Healthineers for the US distribution of the RESPOND-19 Ventilator to their network of healthcare systems, hospitals, and government customers. The RESPOND-19 Ventilator is part of Siemens Healthineers' contribution of cutting-edge technology by enhancing reliable, critical care respiratory care that increases ventilation capacity during a surge in patient capacities, such as during a flu season or a pandemic.
Portable ventilators are widely used in hospitals due to their convenience and faster and continuous care to patients even before they are on the hospital premises. The rising number of hospitals is also expected to fuel the segment’s growth, as they increase the demand for products due to their efficiency and variety of applications. Thus, such factors are expected to drive the market over the forecast period.
To understand key trends, Download Sample Report
North America Dominates the Market, and this Trend is Expected to Continue During the Forecast Period
North America is anticipated to dominate the market over the forecast period owing to the factors such as the increasing prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the presence of well-established healthcare infrastructure, and the presence of key market players in the region.
As per the Society of Critical Care Medicine, the stock of hospital ventilators in the United States was around 160,000 units in Q1 2020. Also, as per the American Association for Respiratory Care, there were over 8.6 million active COVID-19 cases as of July 2022, and an estimated 960,000 Americans needed mechanical help to breathe during the pandemic. Thus, mechanical ventilators experienced a sudden spike in demand in the United States, during the COVID-19 pandemic (2020) which is expected to boost the market growth over the forecast period. Similarly, according to a report published by the Centers for Disease Control and Prevention (CDC), in March 2020, out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. According to a research study by Silvio A. Ñamendys-Silva et al., published in Critical Care February 2021, in Mexico, about 15.3% of hospitalized patients required invasive mechanical ventilation (IMV), and 70.8% of patients received invasive mechanical ventilation (IMV) outside the ICU. Thus, the increasing patient admission in the intensive care unit due to COVID-19 is expected to increase the demand for ventilators and is expected to augment the market growth over the forecast period.
As per the American Lung Association 2021, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease (COPD) causes serious long-term disability and early death, and it demands a higher requirement of ventilators, thus generating revenue for the market. Thus, increasing intensive care admissions and the introduction of ventilation modes such as acute non-invasive ventilation, which avoids lung injury, are likely to drive the growth of the mechanical ventilator market, thereby boosting the market in the region over the forecast period.
To understand geography trends, Download Sample Report
Competitive Landscape
The mechanical ventilation market is moderately competitive. Some of the key players are manufacturing and launching new products, while others are distributing the ventilators, which is fueling the market’s growth. Key market players include Getinge AB, Medtronic PLC, Smiths Medical, Koninklijke Philips NV, and ResMed Inc.
Major Players
Getinge AB
Smiths Medical
ResMed Inc.
Medtronic PLC
Koninklijke Philips NV
Recent Developments
- In January 2022, OES Medical joined the ABHI UK Pavilion at Arab Health 2022 to launch a new mains-powered ICU ventilator to support hospitals in managing oxygen demand.
- In May 2021, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Respiratory Disorders
4.2.2 Increased Global Population and Increasing Number of Healthcare Centers and Hospitals with Rising Demand for Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 Highly Expensive Materials and Processes Involved in the Manufacture of Ventilators and Higher Cost of Healthcare Systems
4.3.2 Growing Incidences of Ventilator-associated Pneumonia
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New EntrantsBargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Mobility
5.1.1 Intensive Care Ventilators
5.1.2 Portable Ventilators
5.2 By Interface
5.2.1 Invasive Ventilation
5.2.2 Non-Invasive Ventilation
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Healthcare
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Getinge AB
6.1.2 Medtronic PLC
6.1.3 Koninklijke Philips NV
6.1.4 Smiths Medical
6.1.5 ResMed Inc.
6.1.6 Dragerwerk AG & Co. KGaA
6.1.7 GE Healthcare
6.1.8 Mindray Medical International Limited
6.1.9 Nihon Kohden Corporation
6.1.10 Vyaire Medical Inc.
6.1.11 Zoll Medical Corporation
*List Not Exhaustive7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Frequently Asked Questions
What is the study period of this market?
The Global Mechanical Ventilators Market market is studied from 2019 - 2027.
What is the growth rate of Global Mechanical Ventilators Market?
The Global Mechanical Ventilators Market is growing at a CAGR of 7.5% over the next 5 years.
Which region has highest growth rate in Global Mechanical Ventilators Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Mechanical Ventilators Market?
North America holds highest share in 2021.
Who are the key players in Global Mechanical Ventilators Market?
Getinge AB, Smiths Medical, ResMed Inc., Medtronic PLC, Koninklijke Philips NV are the major companies operating in Global Mechanical Ventilators Market.
